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Abstract
Background: T cell receptor (TCR) engagement leads to formation of signaling microclusters and induction of rapid and
dynamic changes in the actin cytoskeleton, although the exact mechanism by which the TCR initiates actin polymerization is
incompletely understood. The Vav family of guanine nucleotide exchange factors (GEF) has been implicated in generation
of TCR signals and immune synapse formation, however, it is currently not known if Vav’s GEF activity is required in T cell
activation by the TCR in general, and in actin polymerization downstream of the TCR in particular.
Methodology/Principal Findings: Here, we report that Vav1 assembles into signaling microclusters at TCR contact sites and
is critical for TCR-initiated actin polymerization. Surprisingly, Vav1 functions in TCR signaling and Ca
++ mobilization via a
mechanism that does not appear to strictly depend on the intrinsic GEF activity.
Conclusions/Significance: We propose here a model in which Vav functions primarily as a tyrosine phosphorylated linker-
protein for TCR activation of T cells. Our results indicate that, contrary to expectations based on previously published studies
including from our own laboratory, pharmacological inhibition of Vav1’s intrinsic GEF activity may not be an effective
strategy for T cell-directed immunosuppressive therapy.
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Introduction
In developing and mature T cells, the T cell receptor (TCR)
activates Src family kinases that phosphorylate immunoreceptor
tyrosine-based activation motifs (ITAMs) in CD3 and TCRf
proteins, providing docking sites for Syk/ZAP-70 family kinases.
Subsequently, the recruitment of the adaptors LAT, GADS, and
SLP-76, and enzymes such as Tec family kinases, phosphoinositol-
3 kinase (PI3K), and phospholipase Cc1 (PLCc1), leads to the
generation of the secondary signaling intermediates, 1,4,5-inositol
triphosphate (IP3) and diacylglycerol (DAG), activating intracellu-
lar Ca
++ and mitogen-activated protein kinases (MAPK) (reviewed
in [1,2]). Together, these events promote the transcription of genes
involved in T cell proliferation and differentiation. The engage-
ment of the TCR also leads to rapid and dynamic changes in the T
cell actin cytoskeleton that can be visualized by imaging F-actin. In
a model of TCR stimulation on a planar surface, F-actin is
induced at TCR-surface contact sites, but then spreads circumfer-
entially to the cell periphery driving plasma membrane extensions
such as filopodia and lamellipodia [3]. In addition, recent live cell
imaging studies using total internal reflection fluorescence
microscopy (TIRFM) in combination with stimulatory antibodies
or planar bilayers containing peptide:MHC complexes revealed
the formation of microclusters of signaling proteins including
TCRf, CD3, ZAP-70, SLP-76 and Vav, suggesting that these
structures could be the sites of signal generation [4,5,6,7,8,9].
Nevertheless, while the importance of the actin cytoskeleton in
lymphocytes has been appreciated for over 30 years, the exact
mechanism(s) by which the TCR initiates actin polymerization
remains incompletely understood [10].
Several models have been proposed for TCR-initiated actin
polymerization (reviewed in [10,11,12,13]). While most studies
point to the involvement of WASp/WAVE proteins as the
downstream effectors, important differences exist in the proposed
PLoS ONE | www.plosone.org 1 August 2009 | Volume 4 | Issue 8 | e6599mechanisms regarding how the TCR is linked to actin assembly.
For example, one model suggests that CD3 chains directly recruit
an Nck-WASp complex via Nck SH3 binding to proline-rich
sequences in CD3 [14], providing an explanation of how F-actin
induction could occur at the TCR independently of ITAM
phosphorylation. However, the preponderance of evidence
indicates that tyrosine phosphorylation and the recruitment of
ZAP-70, SLP-76, and LAT are required for TCR initiation of F-
actin assembly, and recent studies suggest that microclusters of
these signaling proteins (also termed proto-synapses) can recruit
WASp to sites of TCR contacts [6,15,16].
In this context, WASp/WAVE-mediated nucleation of actin
filaments, through their interaction with the Arp2/3 complex, can
be induced by Nck binding independently of Rho GTPases
[17,18]. Alternatively, WASp/WAVE activation can be mediated
by Rho GTPases, such as Rac1 and Cdc42, which are activated by
guanine nucleotide exchange factors (GEF), including Vav, aPIX,
bPIX, and DOCK2 [19,20,21,22,23,24]. Vav has been implicated
in T cell cytoskeletal regulation based on its Dbl-homology (DH)
domain, tyrosine phosphorylation, and recruitment to T cell-APC
contacts (reviewed in [25]), although recent studies indicated the
importance of Vav in integrin activation and T cell-APC
conjugate formation, rather than in F-actin assembly [26,27].
Thus, while Vav1 also regulates ERM [28] and MTOC
polarization [26], no conclusive evidence exists, to date, in support
of an essential role for Vav proteins in the TCR initiation of actin
polymerization. In this regard, because studies of T cells lacking all
three Vav proteins revealed redundancy of Vav1 with other Vavs
[29], direct examination of TCR-induced actin polymerization in
Vav1/2/3-deficient (Vav
NULL) T cells should conclusively estab-
lish whether or not the Vav family is essential in this process.
While Vav is considered a Rho GEF, it is unknown if the intrinsic
GEF activity is indeed required for Vav function downstream of
the TCR. In this context, disruption of TCR-induced Ca
++ and
MAPK signaling in T cells lacking all Vav proteins (Vav
NULL)
suggests that Vav may function downstream of the TCR as a
critical linker rather than exclusively as a Rho GEF [29].
Consistent with such a view, GEF-inactivated Vav has been
shown to augment NFAT-dependent transcriptional activation in
Jurkat T cells [30]. In addition, Vav contains several tyrosine
residues that may be involved in direct binding of SH2 domain-
containing proteins [9,31,32]. Thus, it is possible that Vav
mediates TCR signals independently of its intrinsic GEF activity,
however this remains to be tested in T cells lacking all endogenous
Vav proteins.
In this report, we address these unresolved issues. Using live-cell
imaging, we show that Vav forms signaling microclusters at TCR
contact sites, similar to other TCR linker proteins, and
demonstrate that the Vav family is critical for TCR initiation of
actin polymerization. Surprisingly, the intrinsic GEF activity is
dispensable for Vav function in TCR signaling and mobilization of
intracellular Ca
++ fluxes. Here, we propose a model for Vav as a
critical linker in TCR-induced activation of T cells.
Results
Vav proteins are essential for the initiation of actin
polymerization at the TCR
In view of the functional redundancy of Vav proteins, we
decided to examine if the Vav family is required in TCR-initiated
actin polymerization using Vav
NULL T cells lacking all 3 Vav
proteins [29]. To this end, we first analyzed WT T cells by
confocal imaging of F-actin structures at the plane of cell contact
with the stimulatory coverslip, visible by DIC microscopy, and
then in increments along the Z-axis (Fig. 1A) [3,4,6]. Initially, the
cell-contact sites appeared round and did not show significant F-
actin content beyond a small ring along the circumference of the
cell contact. Subsequently, within 2–5 minutes, WT T cells
showed dramatic F-actin accumulation throughout the region of
coverslip contact and formed filopodia and lamellipodia stretching
beyond the circumference of the F-actin ring (Fig. 1A, and data
not shown). This process continued for approximately 10 minutes,
at which time the cell perimeter (Fig. 1B) and F-actin content
(Fig. 1C) reached their maximum. We next analyzed Vav1-
deficient (Vav1
2/2) T cells and found that cell spreading and the
induction of F-actin structures were delayed relative to WT (Fig.
S1), indicating that Vav1 regulates but is not essential for TCR-
induced actin polymerization in this system. In sharp contrast to
WT or Vav1
2/2 T cells, F-actin production and cell spreading of
Vav
NULL T cells was virtually blocked (Fig. 1A,B,C), resembling
non-stimulated cells at all of the time points studied (Fig. 1A).
These results show that the Vav family is critical for the initiation
of TCR-induced actin polymerization and T cell spreading. Thus,
together with the involvement of Vav1 in signaling microclusters
[9], these data indicate that Vav may function as a critical linker
for TCR-initiated actin polymerization, raising the question of
whether or not the intrinsic GEF activity is necessary for its
function in this process.
GEF-inactive Vav1 participates in signaling microclusters
and restores TCR function in J.Vav cells and Vav1-
deficient T lymphocytes
Live-cell imaging studies of T cell-planar surface contacts
revealed microclusters of signaling proteins that included ZAP-70,
LAT, SLP-76, Nck, Grb2, and WASp, which have been
implicated in the initiation of T cell activation and actin
polymerization at the sites of TCR contacts [4,5,6,7,33]. Since
Vav1 has been implicated in T cell cytoskeleton regulation, we
decided to examine its dynamic redistribution in live T cells. To
this end, we generated Vav1-deficient Jurkat cells [34] that express
Vav1-GFP (J.Vav1
WT) at the level of endogenous Vav1 in the WT
parental Jurkat line [9] (Fig. 2). Such cells were analyzed using
stimulatory coverslips and real-time total internal reflection
fluorescence microscopy (TIRFM), allowing visualization of
Vav1-GFP in the direct vicinity (100–200 nm) of plasma
membrane-coverslip contacts. Consistent with our recent report,
Vav1-GFP quickly assembled (within 5–10 seconds of initial
contact) into microclusters at the cell-coverslip interface (Fig. 2A)
[9]. Notably, kymographic analyses of microcluster fluorescence
intensity over time, indicate that Vav1-GFP microclusters are
stable (Fig. 2B–D), and Vav1 showed little, if any, lateral diffusion
as indicated by laser-bleaching (data not shown). Control
experiments using J.Vav cells expressing GFP-only (GFP), or
J.Vav1
WT cells incubated on coverslips with irrelevant antibody or
poly-L-lysine showed no significant microcluster formation (Fig.
S2 and data not shown). To extend these initial observations, we
used confocal imaging and found that TCR-induced Vav1-GFP
microclusters colocalized with SLP-76 microclusters (Fig. 2F and
Fig. S3). Thus, given that the redistribution pattern of Vav was
reminiscent of other signaling molecules implicated in microcluster
formation [4], and that Vav colocalized with SLP-76, these data
suggest that Vav could be involved at the sites of initial TCR-
induced actin polymerization, which is consistent with our finding
that Vav is required for generation of F-actin and cell spreading
(Fig. 1).
To determine if the intrinsic GEF activity of Vav1 is required
for its function in TCR signaling, we first generated J.Vav cells
expressing Vav1 protein with a previously characterized GEF
Vav Function in TCR Signaling
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onco-Vav), fused to GFP (J.Vav1
GEF2) ([9,22,35,36,37] and Fig.
S4). We first examined such J.Vav1
GEF2 c e l l sb yT I R F M ,a si n
experiments described in Fig. 2, and found that, similar to
Vav1
WT,V a v 1
GEF2 generated stable microclusters at the T cell-
stimulatory coverslip interface (Fig. 3A–D). Moreover, similar to
Vav1
WT,V a v 1
GEF2 microclusters colocalized with TCR-
induced SLP-76 microclusters (Fig. S3). In addition, tyrosine
phosphorylation and SLP-76 binding of Vav1
GEF2 in response to
TCR stimulation showed no discernible differences from
Vav1
WT (Fig. 3E). Thus, neither the pattern of Vav1 redistribu-
tion, nor its tyrosine phosphorylation and SLP-76 binding,
appeartobeaffectedbythelossofintrinsicGEFactivity(Fig.3A–
E).
To determine if Vav GEF activity is required for TCR
induction of NFAT and NFkB, we used J.Vav1
WT and
J.Vav1
GEF2 cells transfected with NFAT or NFkB luciferase
reporter-gene constructs and analyzed luciferase activity upon
stimulation with anti-CD3 antibodies (Fig. 3F). As expected, such
treatment led to a strong induction of both NFAT- and NFkB-
dependent luciferase activity in J.Vav1
WT T cells. Notably,
J.Vav1
GEF2 cells showed no statistically significant differences in
activity in this assay as compared to J.Vav1
WT (Fig. 3F) and
responded similarly to PMA and Ionomycin (Fig. S5). These
experiments suggest that, even in the absence of endogenous
Vav1, a GEF-inactive Vav1 is capable of rescuing TCR-induced
NFAT- and NFkB-dependent transcriptional activation. These
observations are consistent with previous studies showing GEF-
independent effects of Vav in this pathway [30]. Strikingly,
however, the same GEF-inactivating mutation completely abol-
ished the ability of Vav to activate NADPH-oxidase in myeloid
cells ([9,36,37], and our unpublished observations). Thus, it
appears that in contrast to the TCR signaling pathway, in myeloid
cells Vav GEF activity is critical for its function in regulating the
NADPH oxidase complex.
Since signaling properties of Jurkat T cells differ in some aspects
from those of primary T cells, for example due to PTEN
deficiency, we decided to examine the requirement for Vav1 GEF
activity in primary T lymphocytes. In this regard, while anti-CD3-
or superantigen SEE-induced proliferation of Vav1
2/2 T
lymphocytes was diminished, as expected based on previously
published studies [38,39,40], expression of retrovirally-encoded
Vav1
GEF2 protein in primary Vav1
2/2 T lymphocytes restored
their proliferative capacity, as compared to Vav1
WT T cells
Figure 1. Vav
NULL T cells show defective TCR-induced actin cytoskeletal reorganization and cell spreading. (A) Staining of F-actin with
Alexa-Fluor-488-phalloidin in WT or Vav
NULL T cells stimulated on anti-CD3-coated coverslips and fixed after 10 minutes. Shown are representative
images of n$10 cells. Optical slices in the XY plane depict the cell-coverslip interface, and Z-stacked images depict the entire cell in the XZ plane. (B)
Cell perimeter was measured in arbitrary units at the membrane-coverslip interface for T cells stimulated as in (A), data are mean6SD of
n$10 images/time point. (C) The relative concentration of F-actin at the membrane-coverslip contact site measured as integrated density (pixel
intensity) in arbitrary units of Alexa-Fluor-488-phalloidin fluorescence within the perimeter of the membrane-coverslip contact site described in (B).
Asterisks (*) indicate p,0.05.
doi:10.1371/journal.pone.0006599.g001
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++ signaling, which is
defective in Vav1
2/2 T cells, was restored in Vav1
GEF2 cells (data
not shown).
Taken together, these results suggest that the intrinsic GEF
activity is dispensable for Vav1 function in J.Vav cells and in
Vav1
2/2 T cells. However, because neither J.Vav cells nor
Vav1
2/2 T lymphocytes show appreciable defects in TCR-
induced actin polymerization (Fig. S1 and data not shown), we
reasoned that the requirement for GEF activity must be
conclusively addressed in T cells in the Vav
NULL background.
Expression of Vav1
GEF2 restores T cell development in
Vav
NULL mice
To address the requirement of Vav GEF activity, without the
complicating issue of compensatory effects of endogenous Vav
proteins, we decided to generate T cells that express Vav1
GEF2 in
Figure 2. Vav1 forms microclusters in response to TCR stimulation. (A) J.Vav1
WT cells were activated on anti-CD3-coated coverslips. Images
were obtained in real time using TIRFM (times, above images). (B) Diagonal lines indicate sections of a representative J.Vav1
WT cell taken for
kymographic analysis. (C) Fluorescence of individual Vav1-GFP microclusters over time (60s) are presented as horizontal ‘‘streaks’’ in kymographs for
sections shown in (B). (D) Mean fluorescence intensity over time (60s) of individual Vav1-GFP clusters in stimulated J.Vav1
WT cells. Shown are
representative images of n=5. (E) Vav1
WT-GFP expression. Shown are immunoblots with anti-Vav1 antibodies and FACS of J.Vav1
WT cells. (F) Vav1-
GFP and SLP-76 microcluster formation in J.Vav1
WT cells, activated on anti-CD3-coated coverslips for 2 mins.
doi:10.1371/journal.pone.0006599.g002
Vav Function in TCR Signaling
PLoS ONE | www.plosone.org 4 August 2009 | Volume 4 | Issue 8 | e6599Figure 3. Vav1
GEF2 forms microclusters and supports TCR-induced transcription and proliferation. (A) J.Vav1
GEF2 cells were plated on
anti-CD3-coated coverslips. Images were obtained in real time using TIRFM (times, above images). (B) Diagonal lines indicate sections of a
representative J.Vav1
GEF2 cell used for kymographic analysis. (C) Fluorescence of individual Vav1
GEF2 microclusters over time (60s) is presented as
horizontal ‘‘streaks’’ in kymographs for sections shown in (B). (D) Mean fluorescence intensity over time of individual Vav1
GEF2 clusters, shown are
representative images of n=5. (E) Tyrosine phosphorylation of Vav1 or SLP-76 immunoprecipitated from anti-CD3-stimulated J.Vav1
WT and
J.Vav1
GEF2 cells, visualized by immunoblotting with anti-phospho-tyrosine antibodies. Binding of SLP-76 to Vav1, determined by reprobing blots with
anti-SLP-76 antibodies. ns=non-stimulated. (F) NFAT or NFkB luciferase reporter assays of anti-CD3-activated J.Vav, J.Vav1
WT and J.Vav1
GEF2 cells,
data are mean6SD n.5 experiments. (G) Proliferation of WT, Vav1
2/2 or GFP
+ Vav1
GEF2 T cells generated by HSCC reconstitution, as indicated,
measured at 48 hr by
3H-thymidine incorporation, n=2. Asterisks (*) indicate p,0.05.
doi:10.1371/journal.pone.0006599.g003
Vav Function in TCR Signaling
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examined if Vav1
GEF2 protein could, by itself, support Vav
NULL T
cell development. To this end, we developed a Vav
NULL-
hematopoietic stem cell complementation (HSCC) approach
and, as a validation of this approach, showed that Vav1
WT-GFP
expression rescued Vav
NULL T cell development (Fig. 4A,B). Thus,
while Vav
NULL mice showed severely reduced populations of both
developing and mature T cells [29], Vav1
WT chimera mice
developed populations of thymocytes and peripheral T lympho-
cytes similar to WT mice (Fig. 4A,B), although the total number of
thymocytes generated in such RAG-chimera is typically somewhat
lower, as compared to WT (Fig. 4A and data not shown). Thus,
having established that the introduction of Vav1
WT rescues
development of Vav
NULL T cells, we next examined the effects
of Vav1
GEF2 in this same assay. Strikingly, both numbers and
percentages of thymocytes and peripheral T cell subsets in
Vav1
WT and Vav1
GEF2 mice were similar (Fig. 4A,B). Impor-
tantly, the levels of expression of Vav1
WT and Vav1
GEF2 proteins
were virtually equal to that of endogenous Vav1 (Fig. 4C). Also,
similar to Vav1
WT, a majority of Vav1
GEF2 thymocytes and
peripheral T cells were GFP
+ (Fig. 4A,B), and these GFP+ cells
contained the mutated Vav1
GEF2, as confirmed by direct
sequencing of genomic DNA from purified peripheral T cells
(data not shown). Together, these results show that GEF-inactive
Vav1 is capable of restoring development of T cells lacking all
endogenous Vav family proteins. We conclude from these
Figure 4. Expression of Vav1
GEF2 restores Vav
NULL T cell development. (A) Flow cytometric analyses of thymocytes from WT, Vav
NULL,
Vav1
WT and Vav1
GEF2 mice. The bottom panel is GFP
+-gated, shown is one representative of n.5 mice. (B) Flow cytometric analyses of WT, Vav
NULL,
Vav1
WT, or Vav1
GEF2 lymph nodes as in (A). The top panel is GFP
+-gated, shown is one representative of n.5 mice. (C) Expression of Vav1
WT and
Vav1
GEF2 proteins in T cell lysates, visualized by immunoblotting with anti-Vav1 antibodies. Protein loading was verified by reprobing blots with
antibodies to Erk2.
doi:10.1371/journal.pone.0006599.g004
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development.
Expression of Vav1
GEF2 rescues Vav
NULL T cell
proliferation and cytokine production
Although the Vav family is necessary for T cell proliferative
responses [29,38,39,40], the requirement for Vav GEF activity is
not known. To address this issue, Vav1
WT and Vav1
GEF2 T cells
generated by Vav
NULL-HSCC were stimulated with anti-CD3
antibodies, in the presence or absence of anti-CD28 antibodies,
and proliferation was measured by
3H-thymidine incorporation
(Fig. 5A). While, as we have previously shown, Vav
NULL T cells
showed essentially no proliferation in this assay [29], surprisingly,
Vav1
GEF2 T cells showed a robust response that was similar to
Vav1
WT at all concentrations of stimulatory antibodies tested
(Fig. 5A and data not shown). As an alternative measure of T cell
proliferation, we used CFSE dye-dilution assays, which also
showed comparable proliferative responses of Vav1
GEF2 and
Vav1
WT T cells (Fig. 5B). Moreover, analyses of T cell
proliferation induced by superantigen SEE-pulsed APCs showed
similar results (Fig. 5C,D), indicating that the intrinsic Vav GEF
activity is not required for T cell proliferation.
Since Vav1-deficiency has been shown to impair generation of
effector T cells and cytokine production with deficient IL-4
expression and enhanced Th1 development [41], we examined if
Vav1 GEF activity may be essential in this process. To this end,
purified naı ¨ve CD4
+CD62L
hi T cells from Vav1
WT or Vav1
GEF2
mice were stimulated under Th1 or Th2 polarizing conditions and
then assayed for IFNc or IL-4 production. Results of these
experiments showed similar cytokine production profiles of
Vav1
WT and Vav1
GEF2 T cells (Fig. 5E). Taken together, these
experiments indicate that while Vav proteins are essential for the
induction of T cell proliferative responses, the intrinsic GEF
activity appears dispensable for Vav function in T cells. Of note,
while previous reports indicated involvement of Vav GEF activity
in CD28 signaling (reviewed in [42]), our results suggest that there
may also exist a GEF-independent mechanism for Vav-mediated
CD28 co-stimulation.
Expression of Vav1
GEF2 rescues defects in TCR signaling,
actin cytoskeleton remodeling, Rac1 activation, and
MTOC polarization
Our previous studies showed defects in TCR-induced Ca
++ and
Ras/MAPK signaling in Vav
NULL T cells [29], however it is not
known if the intrinsic Vav GEF activity is required in these
processes. To address this issue, we examined Ca
++ mobilization in
response to TCR stimulation in Vav1
WT and Vav1
GEF2 T cells
and found that both types of cells showed a similar response
(Fig. 5F). Similarly, activation of Erk-1/2 appeared normal in both
Vav1
WT and Vav1
GEF2 T cells (Fig. 5G). These results indicate
that although the activation of Ca
++ and Erk signaling downstream
of the TCR requires Vav [29], it does not depend on the intrinsic
Vav GEF activity. In this context, in accord with reports of a
defect in TCR activation of Rac1 in Vav1
2/2 T cells, [43,44], we
also found defective TCR-induced Rac1 activation in Vav
NULL T
cells and a modest reduction in Rac1 activation in J.Vav cells
(Fig. 6). Given the disruption of Ca
++ and MAPK signaling in
Vav
NULL T cells, we reasoned that defective Rac activation in
these cells likely results from the loss of Vav linker function.
Consistent with this view, the induction of activated Rac1 in TCR-
stimulated Vav1
WT and Vav1
GEF- T cells was similar, as was that
in J.Vav
WT compared to J.Vav
GEF2 (Fig. 6), indicating that Vav
GEF activity is dispensable for TCR induction of Rac1.
To examine if the GEF activity of Vav is essential for TCR-
induced actin polymerization, Vav1
WT or Vav1
GEF2 T cells were
incubated on stimulatory coverslips, and F-actin structures were
visualized as in Fig. 1. While Vav
NULL T cells completely failed to
spread and form lamellipodia or filopodia following TCR
stimulation (Fig. 1, Table 1), both Vav1
WT and Vav1
GEF2 T cells
showed robust actin polymerization and spreading, virtually
indistinguishable from that of WT T cells (Fig. 7A, Table 1).
These data indicate that while Vav proteins are indispensable for
TCR-induced F-actin remodeling (Fig. 1), the intrinsic GEF
activity does not appear to be required in this process.
Since a recent report implicated Vav in TCR-induced MTOC
polarization [26], we examined the requirement for Vav GEF
activity in this process. These experiments showed that while
MTOC polarization in Vav
NULL T cells was reduced essentially to
background levels, as compared to WT (Fig. 7B, Table 2), MTOC
polarization in Vav1
WT and Vav1
GEF2 cells was similar to WT
(Fig. 7C, Table 2). Collectively, these data indicate that while T
cells require Vav proteins for TCR signaling and cytoskeletal
regulation, Vav GEF activity appears dispensable. Therefore, Vav
appears to mediate TCR signals as a critical linker protein rather
than as a bona fide Rho GEF.
Discussion
Stimulation of T cells with anti-CD3 antibodies immobilized on
a planar surface permits analyses of the initial formation and the
stability of TCR-induced signaling microclusters, or proto-
synapses, in live cells [3,4,5,6,7,33]. In this regard, following
contact of a T cell with a stimulatory surface, ZAP-70, SLP-76,
LAT, GADS, and Grb2 are quickly incorporated into signaling
microclusters [4,5,33]. Here, we report that Vav1 rapidly
assembles into TCR-induced microclusters, and remains stable
and lacks lateral motion. A recent adaptation to visualizing the
dynamic redistribution of TCR-induced microclusters involves
stimulation of T cells with cognate TCR ligands embedded in fluid
lipid bilayers instead of immobilized anti-CD3. Although this
approach allows engaged TCRs to diffuse freely throughout the T
cell membrane and to coalesce at the cSMAC within the
immunological synapse [7,8], unlike immobilized anti-CD3
stimulation, data generated using either approach indicates that
signaling microclusters form at early time points following TCR
stimulation and are relevant sites of TCR signaling initiation and
maintenance.
Vav1 may interact with the TCR/CD3-complex in several
different ways, including via direct interaction with TCRf chains
[45] or by binding to ZAP-70 or SLP-76 [46,47]. In this regard,
together with the observation that Vav1 is rapidly recruited to
signaling microclusters at the initial sites of actin polymerization,
similar to other essential linkers such as LAT, these results indicate
that Vav itself may function as a linker in TCR-induced actin
polymerization, independently of its other potential role as a Rho
GTPase activator. Thus, given that Vav recruitment to ZAP-70,
SLP-76, or LAT is dependent upon tyrosine phosphorylation
[47,48], our results support a model in which TCR-induced actin
polymerization is initiated in the context of phosphorylated
ITAMs. Consistent with this view, our analyses indicate that
Vav colocalizes with other linkers, such as SLP-76, in TCR-
induced microclusters that rapidly form at TCR contacts.
Although Vav1-deficient T lymphocytes and J.Vav cells show
defects in TCR signaling, surprisingly little or no evidence exists in
support of the requirement for Vav1 for TCR-induced actin
polymerization. In this regard, two main issues appear to have
precluded significant inroads. First, the functional redundancy of
Vav Function in TCR Signaling
PLoS ONE | www.plosone.org 7 August 2009 | Volume 4 | Issue 8 | e6599Figure 5. Vav1 GEF activity is not required for T cell function. (A) Proliferation of Vav1
WT or Vav1
GEF2 T cells stimulated with anti-CD3 +/2
anti-CD28 antibodies, measured by
3H-thymidine incorporation at 48 hours, n.3. P+I=PMA and ionomycin. (B) As in (A), with CFSE dye dilution at
72 hours, n.3. (C) Proliferation of Vav1
WT or Vav1
GEF2 T cells stimulated with SEE-pulsed APCs, measured by
3H-thymidine incorporation at 48 hours,
n.3. (D) As in (C), with CFSE dye dilution at 72 hours, n.3. (E) Supernatant cytokines from T cells cultured under Th1 or Th2 polarizing conditions
were analyzed by ELISA, n.4. (F) Ca
++ mobilization by CD4
+ T cells stimulated with anti-CD3 antibodies, n=5. (G) Erk1/2 activation in T cells activated
with anti-CD3 antibodies for indicated time points, visualized by immunoblotting with antibodies against active Erk1/2. Protein loading was verified
by reprobing blots with anti-Erk2 antibodies.
doi:10.1371/journal.pone.0006599.g005
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compensatory effects in cells lacking individual family members.
Second, in studies with T cell-APC conjugates or with other
systems involving an immune synapse, Vav-dependent signals
emanating from integrins and/or costimulatory molecules are
difficult to discriminate from the TCR-specific signals that may
depend upon Vav. Therefore, in this report we examined the
requirement for the entire Vav family in actin reorganization using
Vav
NULL T cells and anti-CD3 stimulation on a planar surface
and find a virtually complete disruption in actin polymerization,
which is the first such direct demonstration. Strikingly, these
defects are rescued by expression of GEF-inactive Vav. In this
regard, several potential scenarios could explain the lack of
requirement for the intrinsic Vav GEF activity. For example, a
previously described SLP-76-Nck-WASp complex may control
actin reorganization independent of Rho-protein involvement
[6,15,16]. Alternatively, a recently described Dynamin2 function
in TCR-induced actin polymerization could contribute Vav-
dependent, but GEF activity-independent, effects [49].
While the requirement for Vav SH2, SH3, CH, and PH
domains for Vav function in TCR signaling is well established
[43,47,50,51], the requirement for the GEF activity remains
controversial [30,34,50,52,53]. In this regard, the truncated form
of Vav1 (with constitutive GEF activity) does not enhance NFAT-
dependent transcription [30,47], suggesting that Vav GEF activity
is not sufficient to propagate signals leading to NFAT. However,
while several reports indicated that GEF activity of Vav1 may be
required in TCR-induced NFAT- and NFkB-mediated transcrip-
tional activation [34,50,52,53], another study showed that Vav1
GEF activity is not required in enhancing NFAT-dependent
transcription [30]. Several potential explanations exist for these
apparent discrepancies. For example, the effects of Vav1 may vary
depending on relative levels of protein expression, as transient
expression of Vav1 in Jurkat cells was shown to potently stimulate
NFAT-dependent signaling, even in the absence of TCR
engagement [30,47]. In this context, overexpression of GEF-
inactive Vav1 could conceivably result in dominant negative
effects on gene transcription [53]. Alternatively, ectopic expression
Figure 6. Expession of Vav1
GEF2 restores TCR-induced Rac1 activation. (A) Rac1 activation in WT and Vav
NULL T cells stimulated with anti-
CD3 antibodies. The graph represents relative increase in Rac1-GTP. (B) Rac1 activation in Vav1
WT and Vav1
GEF2 T cells stimulated with anti-CD3
antibodies, n=2. The graph represents relative increase in Rac1-GTP. (C) Rac1 activation in Jurkat, J.Vav, J.Vav reconstituted with WT Vav1 (J.Vav
WT),
and J.Vav reconstituted with GEF-deficient Vav1 (J.Vav
GEF2). TCL=total cell lysate.
doi:10.1371/journal.pone.0006599.g006
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signaling pathways, for example via a mechanism involving trans-
complementation of the missing GEF activity by the activity of
endogenous (GEF-sufficient) Vav1 protein [30]. Here, we show
that GEF-inactive Vav1, expressed stably at endogenous levels in
J.Vav cells, rescues TCR-induced NFAT- and NFkB-dependent
transcription. In this regard, we used a previously characterized
L278Q loss-of-function mutant [22,35] and verified the loss of
catalytic activity by comprehensive analyses of GDP/GTP
exchange in vitro and by in vivo assays for F-actin induction by
the N-terminally truncated Vav (Fig. S4 and [9,36]). However,
these experiments do not rule out the possibility that the GEF
activity of other Vav proteins, Vav2 and/or Vav3, both of which
are expressed in J.Vav cells, may contribute compensatory effects
Table 1. TCR-induced F-actin polymerization in T cells
activated on stimulatory coverslips.
Total Cells
Counted
# Actin
Polymerized
% Actin
Polymerized
WT 443 402 90.7%
Vav
NULL 427 51 11.9%
Vav1
WT 434 330 76.0%
Vav1
GEF2 400 324 81.0%
doi:10.1371/journal.pone.0006599.t001
Figure 7. Expression of Vav1
GEF2 restores TCR-induced actin polymerization and MTOC polarization in Vav
NULL T cells. (A) Left
panels: Actin polymerization of purified Vav1
WT and Vav1
GEF2 T cells incubated on anti-CD3 antibody-coated coverslips as described in Figure 1. Right
panel: Graphical display of the percentages of the indicated T cells that exhibited actin polymerization after stimulation, n.400 cells per group. (B)
Purified T cells from WT and Vav
NULL mice were either incubated on PBS-coated coverslips (ns=nonstimulated) or were incubated on anti-CD3
antibody-coated coverslips for 30 minutes and MTOCs visualized by staining with fluorescein (FITC)-anti-a-tubulin. (C) Left panels: Purified T cells from
Vav1
WT and Vav1
GEF2 mice were incubated on anti-CD3 antibody-coated coverslips for 30 minutes and MTOCs visualized as described in (B). Right
panel: Graphical display of the percentages of the indicated T cells that exhibited MTOC polarization after stimulation, n.152 cells per group.
doi:10.1371/journal.pone.0006599.g007
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GEF2-mediated signals. To address this issue, we used
Vav
NULL T cells that lack all three endogenous Vav proteins. We
note, however, that other non-Vav GEFs could also be responsible
for contributing compensatory activity, such as bPIX, which is
activated in response to TCR stimulation in J.Vav cells [54].
While mice lacking individual Vav family proteins show partial
to no defects in T lymphocytes, Vav
NULL mice show a severe block
in T cell development [29,38,39,40,55]. We reasoned, given our
earlier observation that Vav1
+/2/Vav2
2/2/Vav3
2/2 mice
(which express only Vav1 but not Vav2 or Vav3) show no
discernible defects in T-lineage cells [29], that reintroduction of
Vav1 alone should be sufficient to rescue Vav
NULL T cell
development and function. Indeed, we found that the expression
of Vav1
WT is capable of completely restoring development and
activation of Vav
NULL T cells. The levels of expression of
recombinant Vav1 in these ‘‘rescued’’ T cells closely approximate
that of endogenous Vav1 in WT T cells (Fig. 4C), a finding that is
notable because in T cells generated by the Vav
NULL-HSCC
assay, Vav1 expression is not controlled by the endogenous
promoter elements but rather by retroviral-based LTRs. Thus,
these data indicate that one or more mechanisms may regulate
Vav1 expression in T cells, or possibly, this could be due to a
developmental advantage of T cell progenitors that express a
certain level of Vav1. While at present we do not completely
understand how the levels of Vav1 expression may be regulated in
T cells, expression of either WT or GEF-inactive Vav1, at levels
indistinguishable from endogenous Vav1, can support T cell
development.
Consistent with recent studies implicating Vav1 in control of
microtubular reorganization [26], Vav
NULL T cells show disrupted
MTOC polarization (Fig. 7, Table 2). While this function of Vav
could, conceivably, require the GEF activity for activation of
GTPases such as Cdc42 that can modulate MTOC polarization
[56], analyses of Vav1
GEF2 T cells suggest that Vav effects on
MTOC polarization are Vav GEF-independent. However, while
Vav appears to be essential for both TCR-mediated regulation
of MTOC polarization and actin polymerization, any GEF
activity(ies) required in these processes could be controlled
by other effectors such as aPIX, bPIX, DOCK2, or DOCK180,
or the RhoA effectors p160ROCK and p190RhoGEF
[19,20,21,23,24,57]. However, recent studies clearly show that
WASp/WAVE-mediated actin polymerization can be induced
by the Arp2/3 complex independently of Rho GTPases, for
example via binding of Nck [3,6]. In this context, the rescue of
TCR-induced F-actin defects in Vav
NULL Tc e l l sb yG E F -
inactive Vav expression indicates that the intrinsic Vav GEF
activity is not essential for actin polymerization downstream of
the TCR. These data suggest that Vav functions as a TCR-
proximal linker critical for cytoskeletal reorganization that could
be Rho GTPase-independent. Interestingly, similar to Vav, the
Rac-GEF kalirin induces lamellipodia formation independently
of its intrinsic GEF activity [58]s u g g e s t i n gt h a tr e g u l a t i o no f
actin dynamics by some GEFs may not require the catalytic
activity of the DH domain.
Alternatively, however, Rac activation downstream of the TCR
may be mediated by other Rho-GEFs, such as aPIX, bPIX, or
DOCK2. Indeed, T cells deficient in DOCK2 show defective
Rac1 activation by the TCR, but unlike Vav
NULL T cells, show no
defects in Ca
++ or MAPK signaling [24], indicating distinct
mechanisms for regulation of Rac and Ras GTPases downstream
of the TCR. In this regard, the function of Vav appears to be as a
TCR linker required for both Rac and Ras signaling. Thus, taken
together, the reduction of specific catalytic activity of the Vav
GEF-mutant used in our study to essentially undetectable levels
(less than 1% of wild type), combined with no evidence for any
local increases in the concentration of the mutant protein, as
judged by TIRFM analyses of activated T cells, and no evidence of
any titratable differences in the ability of Vav1
GEF2 T cells to
respond to TCR stimulation, provide compelling evidence that
defects in TCR signaling (including Ca
++, MAPK, and Rac1
activation), actin polymerization, MTOC polarization and
proliferation of Vav
NULL T cells are due to the loss of adaptor/
linker, rather than GEF, function of Vav. Consistent with effective
reduction of the GEF activity of the Vav1
GEF2 constructs,
combining the GEF-killing mutation with the GEF-activating
mutation (Y174F) completely abolished the effects of the latter [9].
Of note, we obtained similar results using another GEF-inactive
form of Vav (Vav1
E201A/K335A) [59,60,61] (data not shown). Thus,
the preponderance of evidence presented in our report indicates to
us that a scenario in which any residual GEF activity would
account for the rescue of T cell function by the Vav1 L278Q
mutant is unlikely. Moreover, recent reports demonstrate that
expression of the same Vav1
GEF2 mutant (L278Q) in Vav-
deficient myeloid cells does not rescue LPS- or FccR-triggered
oxidative burst [36,37], indicating that in these cells the intrinsic
GEF activity of Vav is essential for its function, in contrast to
TCR-induced signaling.
We also note that because mice congenitally lacking Vav1 show
primarily T-lineage specific defects [62], one could reason that the
intrinsic GEF-activity of Vav1 could be an attractive potential
target for pharmacological inhibition in the context of T cell-
directed immunosuppressive therapies. However, our data pre-
sented here suggest that the inhibition of the Vav1 enzymatic
activity as a GEF would likely not be an effective strategy for
suppressing T cell activation and proliferative expansion.
While Vav proteins also contain a PH domain, implicated in
PIP2 and PIP3 binding and the regulation of Vav plasma
membrane interactions as well as GEF activity [25], a recent
study showed that a mutation rendering Vav1 PH domain
incapable of binding to phosphatidylinositol metabolites leads to
TCR signaling defects [43]. Thus, given the results of our studies
presented in this report, it is possible that the PH domain could
contribute to Vav function in TCR signaling independently of its
effects on GEF activity.
Vav has been among the first phosphotyrosine-proteins
identified in TCR signaling pathways [63,64] and indeed, tyrosine
phosphorylation distinguishes the Vav family from a plethora of
other Dbl proteins. While Vav tyrosine phosphorylation has
mainly been considered in the context of the regulation of the
intrinsic GEF activity [31,65], our data presented in this report
suggest that tyrosine phosphorylation of Vav could also contribute
to its function as a TCR linker for activated T cells. In this regard,
we propose that Vav mediates TCR signals in a GEF-independent
manner.
Table 2. TCR-induced MTOC polarization in T cells activated
on stimulatory coverslips.
Total Cells
Counted
# MTOC
Polarized
% MTOC
Polarized
WT 197 167 84.7%
Vav
NULL 195 77 39.5%
Vav1
WT 152 115 75.7%
Vav1
GEF2 165 134 81.2%
doi:10.1371/journal.pone.0006599.t002
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Generation of Reconstituted J.Vav Cell Lines, Stimulation,
and Immunoblotting
The Vav1-deficient J.Vav cell line was previously described
[34]. To generate J.Vav cell lines expressing Vav1
WT or
Vav1
GEF2 proteins, GFP-tagged Vav1 expression constructs were
transduced into J.Vav cells via ‘‘spinfection’’ with retroviral
particles at RT, 2000 rpm for 90 mins. GFP
+ cells were FACS
sorted and subcloned. Vav1-GFP constructs were generated by
ligation of an XbaI-BamHI Vav1-GFP cDNA fragment into
IRES-GFP-RV digested with XhoI-BamHI replacing IRES-GFP.
Mutagenesis was performed by PCR (Quickchange kit, Strata-
gene, La Jolla, CA) and confirmed by sequencing. Cells were
stimulated with anti-CD3e (clone HIT3a; 1 mg/mL, BD Biosci-
ences, San Diego, CA)+anti-IgG2a (1 mg/mL, Southern Biotech-
nology Assoc., Birmingham, AL), as indicated, and lysed in RIPA
buffer supplemented with a protease inhibitor cocktail (Boehrin-
ger, Ridgefield, CT), 10 mM NaF, and 1 mM Na3VO4. Western
blotting was performed following standard procedures. Primary
antibodies were developed with HRP-conjugated secondary
antibodies (anti-mouse, Zymed, San Francisco, CA; anti-rabbit,
Amersham Biosciences, Piscataway, NJ; anti-sheep, Upstate, Lake
Placid, NY). Immune complexes were detected by enhanced
chemiluminescence (Amersham Biosciences).
TIRFM Imaging. Imaging of dynamic Vav1-GFP microcluster
assembly and movement was performed using TIRF microscopy
as described in [9,66]. Image recording and processing were
performed using AQUACOSMOS software (Hamamatsu Pho-
tonics, Japan) and image analyses were performed using
Metamorph Software (Molecular Devices Corp., Sunnyvale,
CA). Kymographic analysis was performed as in [9]. See
Supplemental Methods S1 for more extensive descriptions.
Actin Polymerization and MTOC Polarization
T cells were purified from LN cell suspensions by removal of B
cells with anti-Ig-coated Dynabeads (Invitrogen, Carlsbad, CA)
using standard procedures. T cells were resuspended in plain
DMEM and incubated on anti-CD3e-coated coverslips (clone
145-2C11, 1 mg/mL, BD Biosciences) for the indicated time
points. Actin polymerization was visualized by staining of F-actin
with Alexa-Fluor-488-phalloidin (Molecular Probes, Eugene, OR).
MTOC polarization was performed as previously described [67].
MTOCs were visualized by staining with fluorescein (FITC)-anti-
a-tubulin (Sigma, St. Louis, MO). Confocal and differential
interference contrast (DIC) images were taken using Zeiss
LSM510 confocal system and analyzed by ImageJ software and
LSM Image Browser software.
Luciferase Assays
Cells were transfected with 5 mg luciferase plasmid containing
NFATx3 binding sites from the IL-2 promoter, or NFkBx2
binding sites from the IFNb promoter. Sixteen hours following
transfection, cells were either left unstimulated or stimulated with
anti-CD3+anti-IgG2a for 6 hours. Luciferase assays were then
performed according to manufacturer’s instructions (Promega,
Madison, WI).
Mice, Cell Suspensions, Antibodies, and Flow Cytometry
Germline Vav1
2/2 and Vav
NULL mice have been previously
described [29,55] and were maintained in the SPF facility of
Washington University School of Medicine according to institu-
tional protocols. Cell suspensions were prepared, counted, and
stained with antibodies following standard procedures. The
following antibody conjugates were used (BD Biosciences):
phycoerythrin (PE) and allophyocyanin (APC)-H129.19 (anti-
CD4) and cytochrome C (CyC)-53–6.7 (anti-CD8a). All samples
were analyzed on a FACSCalibur flow cytometer (Becton
Dickinson) with FlowJo software.
Vav
NULL hematopoietic stem cell complementation
(Vav
NULL-HSCC)
A single dose of 150 mg/kg of 5-flurouracil (10 mg/mL in PBS,
Sigma) was injected into donor mice intraperitoneally. Four to five
days post-injection, donors were sacrificed, and bone marrow
(BM) harvested. BM cells were expanded in media containing 15%
FCS and supplemented with SCF (100 ng/ml, PeproTech, Rocky
Hill, NJ), IL-3 (6 ng/ml, PeproTech), and IL-6 (10 ng/ml,
PeproTech). After 2 days in culture, the cells were retrovirally
transduced via ‘‘spinfection.’’ Infection efficiency and viability of
BM cells was assessed by flow cytometry. RAG2
2/2 recipient
mice were lethally irradiated with 950 Rad (gamma irradiation
(Cs
137), MDS Nordion, Ottawa, Ontario, Canada) and injected
with 250 mL cell suspension (,.25610
6 cells) invtravenously.
Chimera were sacrificed and analyzed 5–7 weeks following
reconstitution.
T Cell Stimulation and Proliferation Assays
Purified T cells were stimulated with soluble anti-CD3e
antibodies (clone 145-2C11, 1 mg/mL, BD Biosciences)+/2
anti-CD28 (clone 37.51, .5 mg/mL, BD Biosciences), or SEE
(1 ng/mL, Toxin Technologies, Sarasota, FL) as indicated, and
3H-thymidine incorporation performed as described in [29]. For
CFSE labeling, cells were labeled with 1 mM CFSE (Molecular
Probes) and stimulated, as indicated, for 72 hrs. Cells were stained
with anti-CD4-APC conjugates and proliferation analyzed by flow
cytometry.
T Cell Polarization and Analysis of Cytokine Production
Naı ¨ve CD4
+CD62L
+ LN T cells FACS sorted from fresh LN
were activated and polarized to Th1 or Th2 as previously
described in [68]. For ELISA, resting cells were stimulated with
anti-CD3 antibodies for 24 hrs. Cytokine concentrations were
measured in culture supernatants using Cytometric Bead Array
(BD Biosciences) according to manufacturer’s instructions.
Ca
++ Fluxes and MAPK Activation
Ca
++ signaling was measured by loading total LN cell
suspensions with Fluo-4-AM (3–5 mg/mL, Molecular Probes).
Cells were stained with anti-CD4-APC conjugates and analyzed
by flow cytometry as described in [29]. Erk1/2 signaling was
measured as previously described [29].
Rac assay. Purified LN T cells were starved for 30 mins in media
lacking serum. Cells were treated with 1 mg/mL anti-CD3
antibodies for 2 mins and Rac assay performed using EZ-Detect
Rac1 Activation Kit (Pierce, Rockford, IL) according to
manufacture’s instructions.
Purification of GST-Rac1 and MBP-Vav1, and guanine
nucleotide exchange assays
Bacterially expressed GST-Rac1 was purified as previously
described in [69]. MBP-Vav1 fusion proteins were expressed in E.
coli strain BL21(DE) followed by purification using amylose resin
according to the manufacture’s protocol (NEB, Beverley, MA),
with the exception that the column was washed with 20 mM Tris,
pH 7.4, 200 mM NaCl after binding the protein to the resin. The
MBP-fusion proteins were eluted with the same buffer containing
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described in [70,71].
Statistical Analysis
Data are expressed throughout as mean+standard deviation.
Data sets derived from the indicated genotypes were compared
using the two-tailed unpaired Student’s t-test. Differences were
considered statistically significant when p,0.05.
Supporting Information
Figure S1 Vav1-deficient T cells show minimal defects in TCR-
induced actin cytoskeletal reorganization and cell spreading. (A)
Purified LN T cells from WT or Vav12/2 mice were plated on
coverslips coated with anti-CD3 antibodies, and cells were
subsequently stained for F-actin. Images captured by confocal
microscopy depict the cell membrane-coverslip interface in the
XY plane as well as Z-stacked images of the entire cell. Images
shown are representative of n.10 cells for each stimulation
condition. (B) T cells were stimulated and stained as in (A). Cell
spreading was determined by measuring the perimeter of the
membrane-coverslip interface as defined by F-actin staining.
Measurements were made for n.10 cells per stimulation
condition. (C) T cells from (B) were analyzed for F-actin content
at the membrane-coverslip interface by measuring the pixel
intensity of Alexa-Fluor-488-phalloidin fluorescence within the
area defined by the perimeter of the membrane-coverslip interface
(integrated density). Measurements were performed in n.10 cells
per condition.
Found at: doi:10.1371/journal.pone.0006599.s001 (0.33 MB TIF)
Figure S2 Vav1 microcluster formation is induced by TCR
stimulation. Live J.Vav cells expressing GFP-only, or J.Vav1WT
cells were incubated on coverslips coated with anti-CD3
antibodies, or with poly L-lysine and imaged in real time using
TIRFM.
Found at: doi:10.1371/journal.pone.0006599.s002 (0.34 MB TIF)
Figure S3 Vav1 colocalizes with SLP-76 in TCR-induced
microclusters. J.Vav, J.Vav1WT, or J.Vav1GEF- cells were
activated on anti-CD3-coated coverslips for 2 minutes followed
by fixation and permeabilization. SLP-76 microclusters were
visualized by staining with anti-SLP-76 antibodies followed by
anti-rabbit-Cy5. Vav1 microclusters are GFP+. Images were
captured by confocal imaging of cells within the plane of contact
with the stimulatory coverslip, shown by internal reflection
microscopy (IRM). Representative images are shown (n$10).
Found at: doi:10.1371/journal.pone.0006599.s003 (2.27 MB TIF)
Figure S4 The Vav1 L278Q mutation abrogates GEF activity.
(A) Stable expression of GFP-tagged Vav1WT and Vav1GEF- in
J.Vav cells was similar to endogenous levels of Vav1 in Jurkats as
demonstrated by immunoblotting with anti-Vav1 antibodies and
by FACS. (B) (left) In vitro GDP-GTP exchange on increasing
concentrations of Rac1 was measured as loss of radiolabeled [3H]-
GDP in the presence of unlabeled GTP and a WT Vav1 MBP-
DH-PH-ZF fusion protein or (middle) a fusion protein containing
the Vav1 DH domain expressing L278Q (MBP-DH(L278Q)-PH-
ZF), corresponding to L213Q in N-terminally truncated ‘‘onco’’
Vav, [22,35]. (right) Kinetics of in vitro GDP-GTP exchange as
shown in left and middle panels. Bottom panel: kinetic values for
GDP-GTP exchange on Rac1 by WT Vav1 MBP-DH-PH-ZF or
GEF-inactive MBP-DH(L278Q)-PH-ZF, as determined by Line-
weaver-Burk plot shown above.
Found at: doi:10.1371/journal.pone.0006599.s004 (0.17 MB TIF)
Figure S5 Activation of NFAT and NFkB luciferase by PMA
and Ionomycin is Vav-independent. NFAT (A) or NFkB (B)
luciferase reporter assays of untreated and PMA and ionomycin-
activated J.Vav, J.Vav1WT and J.Vav1GEF- cells. Data are
mean6SD n.5 experiments.
Found at: doi:10.1371/journal.pone.0006599.s005 (0.09 MB TIF)
Supplemental Methods S1
Found at: doi:10.1371/journal.pone.0006599.s006 (0.06 MB
DOC)
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